Menniti-Ippolito F, Sagliocca L, Da Cas R, Saggiomo G, Di Nardo R, Traversa G
Department of Epidemiology and Biostatistics, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Arch Dis Child. 2001 May;84(5):430-1. doi: 10.1136/adc.84.5.430.
In a case control study of adverse drug reactions in children, the odds ratio of developing a serious mucocutaneous event among users of niflumic acid, adjusted for concomitant use of all other drugs, was 4.9 (95% CI 1.9 to 12.8). Given the availability of safer analgesics and antipyretics, there is no indication, in our opinion, that requires the prescription of substances which bear an increased risk.
在一项关于儿童药物不良反应的病例对照研究中,在考虑所有其他药物合并使用情况进行调整后,使用尼氟酸的儿童发生严重黏膜皮肤事件的优势比为4.9(95%置信区间为1.9至12.8)。鉴于有更安全的止痛和退热药物可供使用,我们认为,没有迹象表明需要开具具有更高风险的药物。